Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics
WATERTOWN, Mass, September 8, 2020 – C4 Therapeutics, Inc. (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs
WATERTOWN, Mass, September 8, 2020 – C4 Therapeutics, Inc. (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs
WATERTOWN, Mass, July 15, 2020 – C4 Therapeutics, Inc. (C4T), a biotechnology company pioneering a new class of small-molecule drugs
–Multiple oncology-focused programs poised to enter clinical trials in 2021 and 2022– WATERTOWN, Mass, June 16, 2020 – C4 Therapeutics, Inc. (C4T), a